Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cancer Research

• Publication date

  2011-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-10-2626PMID 21148070PMCID PMC3077548
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Faculty Opinions recommendation of The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha.

  2010cited by this paper
• The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha.

  2010cited by this paper
• Suppression of cyclin D1 by hypoxia-inducible factor-1 via direct mechanism inhibits the proliferation and 5-fluorouracil-induced apoptosis of A549 cells.

  2010cited by this paper
• Transcriptional activation of hypoxia‐inducible factor‐1α by HDAC4 and HDAC5 involves differential recruitment of p300 and FIH‐1

  2009cited by this paper
• Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses.

  2009cited by this paper
• The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications

  2008cited by this paper
• HIF-1 regulation: not so easy come, easy go.

  2008cited by this paper
• The role of hypoxia-inducible factors in tumorigenesis

  2008cited by this paper
• Myc and Human Papillomavirus Type 16 E7 Genes Cooperate To Immortalize Human Keratinocytes

  2007cited by this paper
• Overexpression of Human Papillomavirus Type 16 Oncoproteins Enhances Hypoxia-Inducible Factor 1α Protein Accumulation and Vascular Endothelial Growth Factor Expression in Human Cervical Carcinoma Cells

  2007cited by this paper
• The human papillomavirus type 18 E6 oncoprotein induces Vascular Endothelial Growth Factor 121 (VEGF121) transcription from the promoter through a p53-independent mechanism.

  2007cited by this paper
• Human papillomavirus causes an angiogenic switch in keratinocytes which is sufficient to alter endothelial cell behavior.

  2007cited by this paper
• The human Mi-2/NuRD complex and gene regulation

  2007cited by this paper
• Histone Deacetylase Inhibitors Repress the Transactivation Potential of Hypoxia-inducible Factors Independently of Direct Acetylation of HIF-α*

  2006cited by this paper
• Tumor hypoxia and cancer progression.

  2006cited by this paper
• Human papillomaviruses target the double-stranded RNA protein kinase pathway.

  2006cited by this paper
• Histone Deacetylase Inhibitors Induce VHL and Ubiquitin-Independent Proteasomal Degradation of Hypoxia-Inducible Factor 1α

  2006cited by this paper
• Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha.

  2006cited by this paper
• Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha.

  2006cited by this paper
• Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF.

  2006cited by this paper
• Metastasis‐associated protein 1 enhances stability of hypoxia‐inducible factor‐1α protein by recruiting histone deacetylase 1

  2006cited by this paper
• Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-alpha.

  2006cited by this paper
• Metastasis-associated protein 1 enhances angiogenesis by stabilization of HIF-1alpha.

  2006cited by this paper
• Negative and positive regulation of HIF-1: a complex network.

  2005cited by this paper
• Differentiation of HPV-containing cells using organotypic "raft" culture or methylcellulose.

  2005cited by this paper
• HPV31 E7 facilitates replication by activating E2F2 transcription through its interaction with HDACs

  2005cited by this paper
• DNA Damage Is a Prerequisite for p53-Mediated Proteasomal Degradation of HIF-1α in Hypoxic Cells and Downregulation of the Hypoxia Marker Carbonic Anhydrase IX

  2004cited by this paper
• Pathogenesis of Human Papillomaviruses in Differentiating Epithelia

  2004cited by this paper
• Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors

  2004cited by this paper
• The Binding of Histone Deacetylases and the Integrity of Zinc Finger-Like Motifs of the E7 Protein Are Essential for the Life Cycle of Human Papillomavirus Type 31

  2004cited by this paper
• The Tumor Suppressor p53 Down-Regulates Glucose Transporters GLUT1 and GLUT4 Gene Expression

  2004cited by this paper
• Mechanisms of Human Papillomavirus-Induced Oncogenesis

  2004cited by this paper
• Histone Deacetylase 7 Associates with Hypoxia-inducible Factor 1α and Increases Transcriptional Activity*

  2004cited by this paper
• Genetic modulation of hypoxia induced gene expression and angiogenesis: relevance to brain tumors.

  2003cited by this paper
• Stabilization and functional impairment of the tumor suppressor p53 by the human papillomavirus type 16 E7 oncoprotein.

  2002cited by this paper
• Biological activities and molecular targets of the human papillomavirus E7 oncoprotein

  2001cited by this paper
• Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes

  2001cited by this paper
• Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.

  2000cited by this paper
• Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.

  2000cited by this paper
• The E7 Oncoprotein of Human Papillomavirus Type 16 Stabilizes p53 through a Mechanism Independent of p19ARF

  1999cited by this paper
• Papillomaviruses in human cancers

  1999cited by this paper
• The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth

  1999cited by this paper
• Expression of the HPV E7 oncoprotein mimics but does not evoke a p53-dependent cellular DNA damage response pathway.

  1999cited by this paper
• Repression of p53 transcriptional activity by the HPV E7 proteins.

  1997cited by this paper
• Patterns and Emerging Mechanisms Review of the Angiogenic Switch during Tumorigenesis

  1996cited by this paper
• Papillomavirus infections — a major cause of human cancers

  1996cited by this paper
• Papillomavirus infections--a major cause of human cancers.

  1996cited by this paper
• In vitro systems for the study and propagation of human papillomaviruses.

  1994cited by this paper
• Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein

  1992cited by this paper
• Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses.

  1992cited by this paper
• A point mutational analysis of human papillomavirus type 16 E7 protein

  1989cited by this paper
• Papillomaviruses in human cancer.

  1987cited by this paper

• Therapeutic targeting of the HPV E7 oncoprotein: Current advances and emerging strategies.

  2026cites this paper
• HPV-Driven Cervical Carcinogenesis: Genetic and Epigenetic Mechanisms and Diagnostic Approaches

  2026cites this paper
• Advances in the Application of Immunotherapy and Targeted-Therapy in Locally Advanced Cervical Cancer

  2025cites this paper
• The roles of sugar metabolism mechanisms and metabolites in viral infections.

  2025cites this paper
• Hypoxia drives cervical cancer progression via OCT4/ORAI3-dependent glycolysis and Ca2+ signaling

  2025cites this paper
• Roles of hypoxia inducible factors in viral infection: Are they a potential therapeutic target?

  2025cites this paper
• Advances in understanding the mechanisms of the human papillomavirus oncoproteins

  2025cites this paper
• Mitochondrial metabolism in laryngeal cancer: Therapeutic mechanisms and prospects.

  2025cites this paper
• Exploring the metabolic alterations in cervical cancer induced by HPV oncoproteins: From mechanisms to therapeutic targets

  2025cites this paper
• Extraction, GC-MS analysis, cytotoxic, anti-inflammatory and anticancer potential of Cannabis sativa female flower; in vitro, in vivo and in silico

  2025cites this paper
• Role of miRNAs, miR-135b-5p & miR-21-5p in metastasis of cervical cancer

  2025cites this paper
• Epigenetic modulation by oncolytic viruses: Implications for cancer therapeutic efficacy.

  2025cites this paper
• Structural analysis of PTPN21 reveals a dominant-negative effect of the FERM domain on its phosphatase activity

  2024cites this paper
• Molecular aspects of cervical cancer: a pathogenesis update

  2024cites this paper
• Establishment of a prognostic model for hypoxia-associated genes in OPSCC and revelation of intercellular crosstalk

  2024cites this paper
• LNMAC Promotes Cervical Squamous Cell Carcinoma Lymphatic Metastasis via Epigenetic Regulation of FGF2‐Induced Lymphangiogenesis

  2024cites this paper
• Digital Spatial Profiling identifies distinct patterns of immuno-oncology-related gene expression within oropharyngeal tumours in relation to HPV and p16 status

  2024cites this paper
• Aspartate-β-hydroxylase and hypoxia marker expression in head and neck carcinomas: implications for HPV-associated tumors

  2024cites this paper
• Cellular metabolism hijacked by viruses for immunoevasion: potential antiviral targets

  2023cites this paper
• E7 Oncogene HPV58 Variants Detected in Northeast Brazil: Genetic and Functional Analysis

  2023cites this paper
• Using digital spatial profiling to analyse onco-immune-related gene expression within oropharyngeal tumours in relation to HPV and p16 status

  2023cites this paper
• Acetylation and Phosphorylation in the Regulation of Hypoxia-Inducible Factor Activities: Additional Options to Modulate Adaptations to Changes in Oxygen Levels

  2023cites this paper
• Hepatitis B Virus-Encoded MicroRNA (HBV-miR-3) Inhibits FIH-1 Expression to Promote Tumor Angiogenesis in HBV-Related Hepatocellular Carcinoma

  2023cites this paper
• Countenance and implication of Β-sitosterol, Β-amyrin and epiafzelechin in nickel exposed Rat: in-silico and in-vivo approach

  2023cites this paper
• Role of signaling pathways in the interaction between microbial, inflammation and cancer

  2023cites this paper
• HDAC4 in cancer: A multitasking platform to drive not only epigenetic modifications

  2023cites this paper
• Combat Against Gynecological Cancers with Blood Vessels as Entry Point: Anti-Angiogenic Drugs, Clinical Trials and Pre-Clinical Nano-Delivery Platforms

  2023cites this paper
• New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions

  2023cites this paper
• Interplay between cellular metabolism and DNA viruses

  2022cites this paper
• Monoclonal antibodies in cervical malignancy-related HPV

  2022cites this paper
• Functions and modulation of PKM2 activity by human papillomavirus E7 oncoprotein (Review)

  2022cites this paper
• Like Brothers in Arms: How Hormonal Stimuli and Changes in the Metabolism Signaling Cooperate, Leading HPV Infection to Drive the Onset of Cervical Cancer

  2022cites this paper
• Angiogenesis: A Pivotal Therapeutic Target in the Drug Development of Gynecologic Cancers

  2022cites this paper
• Two cases showing the effects of bevacizumab on recurrent cervical cancer with pleural effusion

  2022influential citation
• High Risk-Human Papillomavirus in HNSCC: Present and Future Challenges for Epigenetic Therapies

  2022cites this paper
• The Prognostic Role of Baseline Eosinophils in HPV-Related Cancers: a Multi-institutional Analysis of Anal SCC and OPC Patients Treated with Radical CT-RT

  2022cites this paper
• Predictive value of microvessel features for the clinical response to neoadjuvant chemotherapy in cervical squamous carcinoma and the associations with prognosis

  2021cites this paper
• Viral Manipulation of the Host Epigenome as a Driver of Virus-Induced Oncogenesis

  2021cites this paper
• Human Papillomaviruses Target the DNA Damage Repair and Innate Immune Response Pathways to Allow for Persistent Infection

  2021cites this paper
• The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis

  2021cites this paper
• HPV16 E7 Nucleotide Variants Found in Cancer-Free Subjects Affect E7 Protein Expression and Transformation

  2021cites this paper
• Hypoxia and Its Influence on Radiotherapy Response of HPV-Positive and HPV-Negative Head and Neck Cancer

  2021cites this paper
• Pathogen-Induced Epigenetic Modifications in Cancers: Implications for Prevention, Detection and Treatment of Cancers in Africa

  2021cites this paper
• The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation

  2021cites this paper
• Molecular Analysis of the Interaction between Human PTPN21 and the Oncoprotein E7 from Human Papillomavirus Genotype 18

  2021cites this paper
• Histone Modifying Enzymes in Gynaecological Cancers

  2021cites this paper
• HPV and Other Microbiota; Who’s Good and Who’s Bad: Effects of the Microbial Environment on the Development of Cervical Cancer—A Non-Systematic Review

  2021cites this paper
• Efficacy of the combination of endostar with chemotherapy on stage IVb and recurrent metastatic cervical cancer.

  2020cites this paper
• Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma

  2020cites this paper
• Discovery of 2-(2-aminobenzo[d]thiazol-6-yl) benzo[d]oxazol-5-amine derivatives that regulated HPV relevant cellular pathway and prevented cervical cancer from abnormal proliferation.

  2020cites this paper
• Significant association between host transcriptome‐derived HPV oncogene E6* influence score and carcinogenic pathways, tumor size, and survival in head and neck cancer

  2020cites this paper
• Suppression of a Subset of Interferon-Induced Genes by Human Papillomavirus Type 16 E7 via a Cyclin Dependent Kinase 8-Dependent Mechanism

  2020cites this paper
• Enhanced glycogen metabolism supports the survival and proliferation of HPV-infected keratinocytes in condylomata acuminata.

  2020cites this paper
• The Interaction of Human Papilloma Virus Oncoproteins (E6,E7) and Retinoblastoma Protein (pRb) in Angiogenesis Regulation

  2020cites this paper
• The Role of Epigenetics in Cervical Cancer

  2019cites this paper
• HPV Infection: Pathogenesis and Detection

  2019cites this paper
• Molecular mechanisms in progression of HPV-associated cervical carcinogenesis

  2019cites this paper
• Human Papillomavirus 16 E6 and E7 Synergistically Repress Innate Immune Gene Transcription

  2019cites this paper
• Histone deacetylases in virus‐associated cancers

  2019cites this paper
• The Value of Anti-angiogenics in Cervical Cancer Therapy

  2019cites this paper
• Viral hijacking of cellular metabolism

  2019cites this paper
• How Viral and Intracellular Bacterial Pathogens Reprogram the Metabolism of Host Cells to Allow Their Intracellular Replication

  2019cites this paper
• Retraction Note: Molecular mechanisms in progression of HPV-associated cervical carcinogenesis

  2019cites this paper
• HPV-Mediated Resistance to TNF and TRAIL Is Characterized by Global Alterations in Apoptosis Regulatory Factors, Dysregulation of Death Receptors, and Induction of ROS/RNS

  2019cites this paper
• Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer

  2019cites this paper
• The Role of HPV E7 in Maintenance of Cell Transformation

  2019cites this paper
• Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes

  2018cites this paper
• HPV – A different view on Head and Neck Cancer

  2018cites this paper
• The lysine acetyltransferase GCN5 contributes to human papillomavirus oncoprotein E7‐induced cell proliferation via up‐regulating E2F1

  2018cites this paper
• Effects of 60 kDa prolactin and estradiol on metabolism and cell survival in cervical cancer: Co‑expression of their hormonal receptors during cancer progression.

  2018cites this paper
• HPV-Associated Oropharyngeal Cancer in the HIV/AIDS Patient.

  2018cites this paper
• Human papillomavirus E7 induces p63 expression to modulate DNA damage response

  2018cites this paper
• Human papillomavirus type 16 E5-mediated upregulation of Met in human keratinocytes.

  2018cites this paper
• Human Papillomavirus Infection and Lung Cancer

  2018cites this paper
• Downregulation of ribonucleotide reductase subunits M2 induces apoptosis and G1 arrest of cervical cancer cells

  2018cites this paper
• Cdc6 contributes to abrogating the G1 checkpoint under hypoxic conditions in HPV E7 expressing cells

  2017cites this paper
• A compendium of proteins that interact with HIF-1α.

  2017cites this paper
• Hypoxia-inducible factor-1α activation in HPV-positive head and neck squamous cell carcinoma cell lines

  2017cites this paper
• Targeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth

  2017cites this paper
• Human papillomaviruses in epigenetic regulations.

  2017cites this paper
• DNA Methylation of Human Papillomavirus Genomes During Infection and Cancer Progression

  2017cites this paper
• Cdc 6 contributes to abrogating the G 1 checkpoint under hypoxic conditions in HPV E 7 expressing cells

  2017cites this paper
• The HPV E6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets.

  2017cites this paper
• Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer

  2017influential citation
• Intraindividual homogeneity of 18F-FDG PET/CT parameters in HPV-positive OPSCC.

  2017cites this paper
• Molecular mechanisms of human papillomavirus-related carcinogenesis in head and neck cancer

  2017cites this paper
• Interplay Between Microenvironmental Abnormalities and Infectious Agents in Tumorigenesis.

  2017cites this paper
• Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).

  2017cites this paper
• Mechanisms of human papillomavirus and host gene transcriptional deregulation in cervical carcinogenesis

  2017cites this paper
• The human papillomavirus E7 oncoprotein as a regulator of transcription.

  2017cites this paper
• Regulation of the human papillomavirus type 16 late promoter by transcriptional elongation.

  2017cites this paper
• Clinical Trials of Antiangiogenesis Therapy in Recurrent/Persistent and Metastatic Cervical Cancer.

  2016cites this paper
• Hepatitis C virus core protein enhances hepatocellular carcinoma cells to be susceptible to oncolytic vesicular stomatitis virus through down-regulation of HDAC4.

  2016influential citation
• The Involvement of Epigenetic Mechanisms in HPV‐Induced Cervical Cancer

  2016cites this paper
• Overexpression of HPV16 E6/E7 mediated HIF-1α upregulation of GLUT1 expression in lung cancer cells

  2016cites this paper
• Bevacizumab in the Treatment of Cervical Cancer – Current Evidence and Next Steps

  2016cites this paper
• Hostile takeover: Manipulation of HIF-1 signaling in pathogen-associated cancers (Review).

  2016cites this paper
• ERK Signaling Pathway Is Involved in HPV-16 E6 but not E7 Oncoprotein-Induced HIF-1α Protein Accumulation in NSCLC Cells

  2016cites this paper
• Overexpressed HDAC4 is associated with poor survival and promotes tumor progression in esophageal carcinoma

  2016cites this paper
• Metabolic reprogramming: a hallmark of viral oncogenesis

  2016cites this paper